1. Home
  2. GEOS vs INO Comparison

GEOS vs INO Comparison

Compare GEOS & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GEOS

Geospace Technologies Corporation (Texas)

HOLD

Current Price

$7.22

Market Cap

95.1M

Sector

Industrials

ML Signal

HOLD

Logo Inovio Pharmaceuticals Inc.

INO

Inovio Pharmaceuticals Inc.

HOLD

Current Price

$1.14

Market Cap

90.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GEOS
INO
Founded
1980
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
95.1M
90.5M
IPO Year
1997
1999

Fundamental Metrics

Financial Performance
Metric
GEOS
INO
Price
$7.22
$1.14
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$6.75
AVG Volume (30 Days)
144.7K
1.6M
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
54.18
EPS
N/A
N/A
Revenue
$110,803,000.00
$42,220,086.00
Revenue This Year
N/A
$20,156.19
Revenue Next Year
N/A
$421.95
P/E Ratio
N/A
N/A
Revenue Growth
N/A
19.37
52 Week Low
$6.70
$1.03
52 Week High
$29.89
$2.86

Technical Indicators

Market Signals
Indicator
GEOS
INO
Relative Strength Index (RSI) 35.74 41.74
Support Level N/A $1.03
Resistance Level $9.03 $1.23
Average True Range (ATR) 0.61 0.06
MACD -0.04 -0.00
Stochastic Oscillator 20.72 22.92

Price Performance

Historical Comparison
GEOS
INO

About GEOS Geospace Technologies Corporation (Texas)

Geospace Technologies Corp is engaged in designing and manufacturing sophisticated technology solutions for applications in smart water management, energy exploration, as well as industrial and Internet of Things. Its seismic equipment is used to locate, characterize, and monitor hydrocarbon reservoirs and is also marketed for vibration monitoring, security, and geotechnical uses. The company also produces non-seismic products such as Hydroconn cables, imaging equipment, remote shutoff water valves, and IoT platforms, and provides contract manufacturing services. The company's business segments includes Smart Water, Energy Solutions and Intelligent Industrial. The majority of its revenue is generated from the Energy Solutions segment.

About INO Inovio Pharmaceuticals Inc.

Inovio Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer and infectious diseases. INOVIO's platform harnesses the power of in vivo protein production, featuring optimized design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. Its candidate is INO-3107 for the treatment of recurrent respiratory papillomatosis (RRP), a chronic, rare and debilitating disease of the respiratory tract caused by HPV infection. In its completed Phase 1/2 clinical trial of INO-3107 for the treatment of HPV-6 and HPV-11-associated RRP.

Share on Social Networks: